| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/19/2014 | US20140170073 Nanoparticulate probe for in vivo monitoring of tissue oxygenation |
| 06/19/2014 | US20140170072 Therapeutic methods and compositions for solid delivery |
| 06/19/2014 | US20140170071 Modified Pyrazine Derivatives and Uses Thereof |
| 06/19/2014 | US20140170070 Stable colloidal gold nanoparticles with controllable surface modification and functionalization |
| 06/19/2014 | US20140170069 Assessment of coronary heart disease with carbon dioxide |
| 06/19/2014 | US20140170068 Biomarker for coronary artery disease |
| 06/19/2014 | US20140170066 Integrin targeting agents and in-vivo and in-vitro imaging methods using the same |
| 06/19/2014 | US20140170064 Methods and compositions for radiohalogen protein labeling |
| 06/18/2014 | EP2741787A2 Imaging using sets of carbon nanotubes |
| 06/18/2014 | EP2741786A1 Polynucleotide, polypeptide, animal model and method for the development of complement system modulators |
| 06/18/2014 | CN103874512A Selective delivery molecules and methods of use |
| 06/18/2014 | CN103874511A Brain tumor targeting peptides and methods |
| 06/18/2014 | CN103874482A Liposome composite body |
| 06/18/2014 | CN103864833A Axial end hydroxyl substituted silicon phthalocyanine and self-assembling body thereof |
| 06/18/2014 | CN103861157A MRI development embolism microballoon based on gadolinium alginate |
| 06/18/2014 | CN103861129A Recombinant human endostatin developer and its preparation method |
| 06/18/2014 | CN103861127A SPIO-shRNA (superparamagnetic iron oxide-short hair ribonucleic acid) molecular probe with dual actions of MR (magnetic resonance) gene imaging and targeting therapy |
| 06/18/2014 | CN103861126A Preparation method and application of supramolecular nanoscale polymer for multi-functional imaging |
| 06/18/2014 | CN103861125A Novel penicillin skin test freeze-dried powder and preparation process thereof |
| 06/18/2014 | CN103861124A Preparation method of platinum nanoclusters and application of platinum nanoclusters in tumor imaging agents and apoptosis agents |
| 06/18/2014 | CN103861123A Diagnosis-treatment integrated nanometer material, diagnosis-treatment integrated nanometer preparation and preparation method of nanometer preparation |
| 06/18/2014 | CN103858820A Preparing method for small-sized pig 2-type diabetes model |
| 06/18/2014 | CN103858814A Research model manufacture of diabetes early intervention and through alloxan |
| 06/18/2014 | CN103301483B Preparation of supramolecular dendritic nano aggregate for magnetic resonance imaging contrast |
| 06/18/2014 | CN102711840B Liposome nanoparticles for tumor magnetic resonance imaging |
| 06/18/2014 | CN102250840B Human pancreatic cancer cell line and its application |
| 06/17/2014 | US8753685 Stabilized, biocompatible gold nanoparticles |
| 06/17/2014 | US8753609 Fluid bed meal containing a marker and methods of making |
| 06/17/2014 | US8753608 Complex and contrast agent for photoimaging using the same |
| 06/17/2014 | US8753606 Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons |
| 06/17/2014 | US8753605 Imaging probes, methods of making imaging probes, and methods of imaging |
| 06/12/2014 | WO2014089500A1 A METHOD OF REDUCING BRAIN AMYLOID PLAQUES USING ANTI-Aß ANTIBODIES |
| 06/12/2014 | WO2014089247A2 Modular polymer hydrogel nanoparticles and methods of their manufacture |
| 06/12/2014 | WO2014086942A1 Conjugates of the b-subunit of shiga toxin for use as contrasting agents for imaging and therapy |
| 06/12/2014 | WO2014086938A1 Novel inducible animal models of stress behavior |
| 06/12/2014 | WO2014086835A1 Conjugates of proteins and multivalent cell-penetrating peptides and their uses |
| 06/12/2014 | WO2014058179A3 Low-density lipoprotein analogue nanoparticles, and composition comprising same for targeted diagnosis and treatment of liver |
| 06/12/2014 | WO2013186690A3 Radiolabeled analog(s) of compound 0118 and use thereof in connection with pet and/or spect imaging to determine whether a pharmaceutical containing compound 0118 is a candidate cancer treatment for a patient |
| 06/12/2014 | US20140162900 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 06/12/2014 | US20140161734 Hydrophilic nanoparticles surface-modified with monosaccharide phosphate or monosaccharide phosphate derivatives, its colloidal solution and use thereof |
| 06/12/2014 | US20140161733 Biomarker-targeting contrast agents and their use in magnetic resonance imaging for detection of atherosclerotic plaque |
| 06/12/2014 | US20140161732 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 06/12/2014 | US20140161730 Magnetic graphene-like nanoparticles or graphitic nano- or microparticles and method of production and uses thereof |
| 06/12/2014 | US20140161728 Composition for detecting biofilms on viable tissues |
| 06/12/2014 | US20140161727 Optical-imaging probe for detecting sentinel lymph nodes which contains a composite of poly-gamma-glutamic acid and an optical-imaging die |
| 06/12/2014 | US20140161726 Reconstitutable Microsphere Compositions Useful As Ultrasonic Contrast Agents |
| 06/12/2014 | US20140161725 Molecular Imaging of Cancer Cells In Vivo |
| 06/12/2014 | US20140161724 Compositions and Imaging Methods Comprising Detectably Labeled Phosphatidylethanolamine-Binding Peptides |
| 06/12/2014 | DE102012222486A1 Verfahren und Vorrichtung zur Erzeugung eines Bildes eines vorbestimmten Teils eines Auges Method and apparatus for forming an image of a predetermined part of an eye |
| 06/12/2014 | DE102012018076B4 Klebender Funktionsstreifen zur transkutanen Fluoreszenzmessung sowie zugehörige Herstellungsverfahren und Verwendungen Adhesive strip function for transcutaneous measurement of fluorescence and related manufacturing methods and uses |
| 06/11/2014 | EP2740491A1 Conjugates of the B-subunit of shiga toxin for use as contrasting agents for imaging and therapy |
| 06/11/2014 | EP2740353A1 Novel inducible animal models of stress behavior |
| 06/11/2014 | EP2739315A2 Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality |
| 06/11/2014 | EP2739291A2 Oxide ferrimagnetics with spinel structure nanoparticles and iron oxide nanoparticles, biocompatible aqueous colloidal systems comprising nanoparticles, ferriliposomes, and uses thereof |
| 06/11/2014 | CN103857384A Method for the synthesis of porphyrin-phospholipid conjugates |
| 06/11/2014 | CN103849632A S1 gene of low virulent strain of infectious bronchitis and low virulent strain and application thereof |
| 06/11/2014 | CN103845743A Gold particle-loaded silica multi-mode contrast agent and high intensity focused ultrasound (HIFU) synergist |
| 06/11/2014 | CN103845742A Multifunctional nano diagnosis system and preparation method thereof |
| 06/11/2014 | CN103845741A Dual-mode fluorescent/magnetic resonance imaging contrast agent based on mesoporous silica and preparation thereof |
| 06/11/2014 | CN103845740A Capsule of silver-bearing marker |
| 06/11/2014 | CN103845739A Asymmetric dimethylarginine hydrolytic enzyme freeze-dried powder injection and preparation method thereof |
| 06/11/2014 | CN102994466B Human protein NDUFA10 interacting with transgenic plant exogenous Bt protein |
| 06/10/2014 | US8748403 Modulation of HSV infection |
| 06/10/2014 | US8748087 Sequence of reverse transcriptase gene and method of use |
| 06/10/2014 | US8747892 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 06/10/2014 | US8747863 Vaccine for shigella |
| 06/10/2014 | US8747812 Aqueous negative contrast medium for CT imaging of the gastrointestinal tract and the preparation method thereof |
| 06/10/2014 | US8747811 Perylenequinone derivatives and uses thereof |
| 06/10/2014 | US8747810 Compositions and methods for imaging tissues, organs and tumors |
| 06/10/2014 | US8747808 Radiolabeled annexins |
| 06/05/2014 | WO2014085530A1 Methods of identifying surrogate imaging agents for alpha emitter radiopharmaceuticals and their use in treatment of disease |
| 06/05/2014 | WO2014083546A2 Method of determining effect of anti-obesity molecule |
| 06/05/2014 | US20140157444 Wdr13 as a novel biomarker useful for treating diabetes and cancer |
| 06/05/2014 | US20140155743 Imaging using sets of carbon nanotubes |
| 06/05/2014 | US20140155718 Device and method for measuring an analyte under the nail |
| 06/05/2014 | US20140155579 Dual specificity antibodies and methods of making and using |
| 06/05/2014 | US20140154701 Humanized fc gamma r mice |
| 06/05/2014 | US20140154186 Bacteriochlorin imides |
| 06/05/2014 | US20140154185 Use of non-labeled sugars and detection by mri for assessing tissue perfusion and metabolism |
| 06/05/2014 | US20140154184 Time-gated fluorescence imaging with si-containing particles |
| 06/05/2014 | US20140154183 Novel [f-18]-labelled l-glutamic acid and l-glutamine derivatives (i), their use and processes for their preparation |
| 06/05/2014 | US20140154181 Rgd-containing peptidomimetics and uses thereof |
| 06/05/2014 | US20140154179 Cxcr7 antagonists |
| 06/05/2014 | US20140154178 Methods of detecting myelin basic protein |
| 06/05/2014 | DE102012023344A1 Vorrichtung und Verfahren zur Röntgenfluoreszenzanalyse von Kontrastmittelverteilungen Apparatus and method for X-ray fluorescence analysis of contrast distributions |
| 06/04/2014 | EP2736533A2 Selective delivery molecules and methods of use |
| 06/04/2014 | CN103834618A Coxsackie A16 type virus mutant strain capable of effectively infecting mice |
| 06/04/2014 | CN103830752A Preparation method and use of degradable polymer nano-microcapsules |
| 06/04/2014 | CN103830751A Trace gadolinium-doped manganese oxide nanoparticles for treating brain glioma |
| 06/04/2014 | CN103830750A Gastrointestinal contrast agent containing Chinese herb extract |
| 06/04/2014 | CN103830749A Gastrointestinal contrast agent |
| 06/04/2014 | CN103830748A Method for detecting immunogenicity of CA16 antigen in inactivated vaccine |
| 06/04/2014 | CN102895678B Liver-targeted magnetic resonance imaging contrast agent based on oleanolic acid and preparation method thereof |
| 06/04/2014 | CN102776220B Construction of brucellosis A19 molecular marker vaccine strain and determination of virulence and immunogenicity |
| 06/04/2014 | CN102311454B Compound lipid containing porphyrin ring functional groups, preparation method and application thereof |
| 06/03/2014 | US8744165 Method and apparatus for stain separation in digital pathology images |
| 06/03/2014 | US8742073 Method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
| 06/03/2014 | US8741812 Class of sterol ligands and their uses in regulation of cholesterol and gene expression |
| 06/03/2014 | US8741575 Methods of predicting high grade gliomas using senescence associated genes |
| 06/03/2014 | US8741351 Microspheres for active embolization |